Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K 4

Summary: An antibacterial substance (LIQ 4) produced by Streptococcus faecalis var. liquefaciens K 4 was isolated in extracellular and cell associated form. It markedly inhibited the growth of Gram-positive bacteria, whereas only a few Gram-negative bacteria were susceptible. LIQ 4 was purified by hydrophobic chromatography (Servachrome XAD-2; octyl-Sepharose CL-4B; Sephadex LH 60) and Sephacryl S-200. TLC yielded a fluorescent spot as the active component and several inactive ninhydrin-positive substances. These contaminating peptides strongly adsorbed to LIQ 4 and could only be removed by repeated reversed phase HPLC. Furthermore, HPLC separated LIQ 4 into seven closely related substances. All showed strong fluorescence under UV light, stained yellow with ninhydrin, and contained aspartate and lysine after acid hydrolysis. The molecular weight was estimated by Amicon ultrafiltration to be less than 2000. LIQ 4 was stable at 80°C (30 min) and pH 2, but considerably inactivated above pH 8. It was apparently affected by proteolytic enzymes, but the activity could be fully restored upon heating.

[1]  V. Lorenzo,et al.  Antibiotics from gram-negative bacteria: do they play a role in microbial ecology? , 1984 .

[2]  K. T. Holland,et al.  Production and partial purification of a peptide antibiotic from Staphylococcus epidermidis. , 1983, The Journal of applied bacteriology.

[3]  H. Sahl,et al.  Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. , 1981, Journal of general microbiology.

[4]  J. Tagg,et al.  Bacteriocin production by Streptococcus salivarius strain P. , 1981, Canadian journal of microbiology.

[5]  T. Mitsuoka,et al.  Streptococcus faecium-derived antibacterial substance antagonistic to Bifidobacteria , 1980, Antimicrobial Agents and Chemotherapy.

[6]  T. Nakamura,et al.  Sanguicin, a bacteriocin of oral Streptococcus sanguis , 1979, Antimicrobial Agents and Chemotherapy.

[7]  J. Grigo,et al.  Staphylococcal micrococcins. II. Isolation, purification and identification. , 1975, Arzneimittel-Forschung.

[8]  J. Walker Biosynthesis of the monoguanidinated inositol moiety of bluensomycin, a possible evolutionary precursor of streptomycin. , 1974, The Journal of biological chemistry.

[9]  G. Vogels,et al.  Production and Purification of a Staphylococcus epidermidis Bacteriocin , 1972, Journal of bacteriology.

[10]  R. Facklam Recognition of group D streptococcal species of human origin by biochemical and physiological tests. , 1972, Applied microbiology.

[11]  H. Brandis Bacteriocine und bacteriocin-ähnliche Substanzen , 1966, Deutsche medizinische Wochenschrift.

[12]  T. Su Micrococcin, an antibacterial substance formed by a strain of Micrococcus. , 1948, British journal of experimental pathology.

[13]  J. Pringle,et al.  Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. , 1972, Methods in enzymology.